Integrity Applications, Inc. announced that it has appointed David C. Klonoff, MD as Chair of the Company’s Scientific Advisory Board. Dr. David Klonoff is a world-renowned endocrinologist specializing in diabetes technology. He is currently the Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF. Dr. Klonoff has been a Principal Investigator on over 120 clinical trials of diabetes drugs and devices. He was the lead investigator for the first randomized controlled multicenter trial of an outpatient artificial pancreas product, whose results were published in the New England Journal of Medicine.